Clinical Trial Update: Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA) [Phase 4]

View source ↗

Summary

Phase 4 trial update indicating completed study of iodixanol as a contrast agent for multidetector-row CT coronary angiography in patients with coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• VISIPAQUE (IODIXANOL)

Snippet

Sponsor: GE Healthcare | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED